Evidence map›Paper›PMID 38526216›Full record

ArticleToxicological sciences : an official journal of the Society of Toxicology2024

The aryl hydrocarbon receptor differentially modulates the expression profile of antibody isotypes in a human B-cell line.

Mili S Bhakta-Yadav, Kaulini Burra, Nasser Alhamdan, Clayton P Allex-Buckner, Courtney E W Sulentic

Open access · greenAbstract read
In one paragraph

Article in Toxicological sciences : an official journal of the Society of Toxicology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Mili S Bhakta-YadavDepartment of Pharmacology & Toxicology, Boonshoft School of Medicine, Wright State University, Dayton, Ohio 45435, USA.
Kaulini BurraDepartment of Pharmacology & Toxicology, Boonshoft School of Medicine, Wright State University, Dayton, Ohio 45435, USA.
Nasser AlhamdanDepartment of Pharmacology & Toxicology, Boonshoft School of Medicine, Wright State University, Dayton, Ohio 45435, USA.
Clayton P Allex-BucknerDepartment of Pharmacology & Toxicology, Boonshoft School of Medicine, Wright State University, Dayton, Ohio 45435, USA.
Courtney E W SulenticDepartment of Pharmacology & Toxicology, Boonshoft School of Medicine, Wright State University, Dayton, Ohio 45435, USA.ORCID 0000-0003-1160-8217
Wright State University · US

Funding

3'alpha enhancer regulation by AhR and NF-kappaB/Rel proteinsR01ES014676 · NIEHS · WRIGHT STATE UNIVERSITY · PI SULENTIC, COURTNEY ELIZABETH WILLIAMS · 2007 to 2011
$1.4M
Department of Pharmacology & Toxicology, Boonshoft School of MedicineNIEHS NIH HHS NIEHS R01ES014676NIEHS NIH HHS R01 ES014676Wright State University
6 · The paper itself

Abstract

2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) is a persistent environmental contaminant and high affinity ligand for the aryl hydrocarbon receptor (AhR). In animal models, AhR activation by TCDD generally inhibits antibody secretion. However, it is less clear if this translates to human antibody production. Using a human Burkitt lymphoma B-cell line (CL-01) that can be stimulated to secrete Ig and undergo class switch recombination to other Ig isotypes, the current study evaluated the effects of AhR activation or antagonism on the human Ig isotypic expression profile with CD40L+IL-4 stimulation. Our results suggest that AhR agonists (TCDD and indirubin) have little to no effect on IgM or IgA secretion, which were also not induced with stimulation. However, AhR activation significantly inhibited stimulation-induced IgG secretion, an effect reversed by the AhR antagonist CH223191. Evaluation of Ig heavy chain (IgH) constant region gene expression (ie Cμ, Cγ1-4, Cα1-2, and Cε that encode for IgM, IgG1-4, IgA1-2, and IgE, respectively) demonstrated differential effects. While Cμ and Cα2 transcripts were unaffected by stimulation or AhR agonists, AhR activation significantly inhibited stimulation-induced Cγ2-4 and Cε mRNA transcripts, which was reversed by AhR antagonism. Notably, AhR antagonism in the absence of exogenous AhR ligands significantly increased IgG and IgA secretion as well as the expression of Cγ2-4 and Cε. These results suggest that modulation of AhR activity differentially alters the IgH isotypic expression profile and antibody secretion that may be partly dependent on cellular stimulation. Since a variety of chemicals from anthropogenic, industrial, pharmaceutical, dietary, and bacterial sources bind the AhR, the ability of environmental exposures to alter AhR activity (i.e. activate or inhibit) may have a direct influence on immune function and antibody-relevant disease conditions.

Indexed as

B-LymphocytesImmunoglobulin IsotypesPolychlorinated DibenzodioxinsReceptors, Aryl HydrocarbonBasic Helix-Loop-Helix ProteinsCD40 LigandCell Line, TumorEnvironmental PollutantsHumansImmunoglobulin Class SwitchingIndolesAHR protein, humanBasic Helix-Loop-Helix ProteinsCD40 LigandEnvironmental PollutantsImmunoglobulin IsotypesIndolesPolychlorinated DibenzodioxinsReceptors, Aryl Hydrocarbonantibody productionaryl hydrocarbon receptorB lymphocytesimmunoglobulin heavy chainTCDD/dioxinstransactivation

Identifiers

PMID38526216
PMCPMC11131011
OpenAlexW4393145070

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.